Literature DB >> 6879508

Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).

D I Cargill, D S Cohen, R G Van Valen, J J Klimek, R P Levin.   

Abstract

PAF-induced aggregation and dense granule release (ATP release) were investigated in human, primate, guinea pig, rabbit and rat platelet-rich plasma (PRP). Guinea pig PRP was most sensitive to PAF, followed by rabbit and then human. PRP from rats and primates did not aggregate or release when exposed to PAF. In guinea pig and rabbit PRP, release was independent of aggregatory response. In human PRP high doses of PAF (5 X 10(-7) M) caused maximum aggregation and a biphasic ATP release, whilst lower concentrations (3 X 10(-8) M) induced biphasic aggregation and one phase of ATP release concomitant with the second phase of aggregation. Aggregation and ATP release induced by PAF in guinea pig and rabbit PRP is dependent upon Ca++ levels, whilst the response of human platelets is relatively independent of the Ca++ level above a certain threshold concentration. The PRP from the three species which aggregated with PAF also demonstrate the phenomenon of desensitization.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6879508

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.

Authors:  S Chakrabarty; D S Fluck; N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.

Authors:  T Mikami; K Fukushi; M Ishitani; K Ishitani; S Suzuki; M Suzuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).

Authors:  N Imanishi; Y Komuro; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 4.  Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome.

Authors:  Nicholas G Kounis; Ioanna Koniari; Anastasios Roumeliotis; Grigorios Tsigkas; George Soufras; Nicholas Grapsas; Periklis Davlouros; George Hahalis
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

5.  Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.

Authors:  F Fouque; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

6.  Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.

Authors:  W M Hu; P C Choy; R Y Man
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

7.  Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.

Authors:  M B da Silva; C Dessy; J Coghe; J L David; P Lekeux
Journal:  Vet Res Commun       Date:  1998-06       Impact factor: 2.459

8.  Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.

Authors:  D Lauri; C Cerletti; G de Gaetano
Journal:  Agents Actions       Date:  1986-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.